WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Roland Wilhelm KolbeckCSci2026-08-0112,385$5.20
$64.40kSell
Jesse Wayne HallChief Medical Officer2026-05-019,330$4.41
$41.15kSell
Braden Michael Leonard10% Owner2026-04-23300,000$4.53
$1.36MSell
Kevin BalthaserChief Financial Officer2026-03-01677$2.87
$1.94kSell
Neal WalkerCEO2026-02-0318,611$3.47
$64.58kSell
Kevin BalthaserChief Financial Officer2026-02-036,449$3.47
$22.38kSell
James LoeropChief Business Officer2026-02-035,937$3.47
$20.60kSell
Kevin BalthaserChief Financial Officer2026-02-014,984$3.51
$17.49kSell
James LoeropChief Business Officer2026-02-0110,686$3.51
$37.51kSell
James LoeropChief Business Officer2026-01-026,171$2.88
$17.77kSell

1 of 2

ACRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard28.70%42,243,975$266.35MInsider
Fmr LLC5.87%8,637,727$54.46MInsider
Ra Capital Management LP2.95%4,339,299$27.36MInsider
Albert Cha2.85%4,191,397$26.43MInsider
Anand Mehra2.84%4,177,456$26.34MInsider
James E. Flynn2.80%4,123,266$26.00MInsider
Vivo Ventures VII LLC1.94%2,858,569$18.02MInsider
Sofinnova Venture Partners VIII LP1.56%2,289,480$14.44MInsider
Neal Walker1.05%1,543,886$9.73MInsider
Foresite Capital Management III LLC0.85%1,258,243$7.93MInsider

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS0.08%53.53%Net SellingNet Selling
CSTL0.09%15.55%Net SellingNet Selling
OPK0.03%99.97%Net BuyingNet Selling
FLGT0.06%48.51%Net SellingNet Selling
FRNM0.01%24.63%Net BuyingNet Buying
View Top Diagnostic & Research Stocks

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 0.08% institutional shareholders, 53.53% Aclaris Therapeutics insiders, and 46.39% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 42.24M shares representing 28.70% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $266.35M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.